Sanders Corazon (Corsee) D. 4
4 · BeOne Medicines Ltd. · Filed May 27, 2026
Research Summary
AI-generated summary of this filing
BeOne Medicines (ONC) Director Corazon D. Sanders Sells 212 Shares
What Happened
Corazon (Corsee) D. Sanders, a director of BeOne Medicines Ltd. (ONC), disposed of 212 American Depositary Shares (ADS) on May 22, 2026. The shares were sold at $309.59 each, generating proceeds of $65,633. The filing indicates the sale was made to satisfy a mandatory tax-withholding requirement tied to the vesting of restricted share units (RSUs).
Key Details
- Transaction date and price: 2026-05-22, 212 ADS sold at $309.59 per ADS (total $65,633).
- Shares owned after transaction: not specified in the Form 4 provided.
- Footnotes: F1 — each ADS represents 13 ordinary shares; F2 — sale effected pursuant to mandatory tax withholding under the Reporting Person’s RSU award agreement (vesting schedule and change-in-control/termination acceleration described).
- Filing timeliness: Form filed 2026-05-27; this appears to be within the two-business-day SEC filing window for Section 16 insiders (timely).
Context
The sale was done to cover tax withholding on vested RSUs (a common, routine reason for insider sales) rather than a separate discretionary open-market divestiture. Because each ADS equals 13 ordinary shares, the 212 ADS correspond to 2,756 underlying ordinary shares. The RSU footnote describes standard vesting and accelerated-vesting on certain events; the transaction should be read as tax-withholding related rather than a direct signal about the director’s view of the company.
Insider Transaction Report
- Sale
American Depositary Shares
[F1][F2]2026-05-22$309.59/sh−212$65,633→ 0 total
- 54,470
Ordinary Shares
Footnotes (2)
- [F1]Each American Depositary Share represents 13 Ordinary Shares.
- [F2]The sale was effected pursuant to a mandatory tax withholding provision in the Reporting Person's restricted share unit award agreement in connection with the vesting of a restricted share unit award previously granted to the Reporting Person. The restricted share units shall become fully vested on the earlier to occur of the first anniversary of the grant date or the date of the next annual general meeting; provided, however, that all vesting shall cease if the director resigns from the board of directors or otherwise ceases to serve as a director, unless the board determines otherwise. Unvested securities are subject to accelerated vesting upon a change in control or certain termination events.